A Phase 3, Randomized, Double-blind, Placebo- and Active-Controlled Study of the Efficacy and Safety of Suzetrigine in Subjects With Pain Associated With Diabetic Peripheral Neuropathy
A Phase 3, Randomized, Double-blind, Placebo- and Active-Controlled Study of the Efficacy and Safety of Suzetrigine in Subjects With Pain Associated With Diabetic Peripheral Neuropathy
The purpose of this study is to evaluate the efficacy, safety, and tolerability of Suzetrigine (SUZ) in participants with pain associated with diabetic peripheral neuropathy (DPN).
Key Inclusion Criteria:
Key Exclusion Criteria:
Other protocol defined Inclusion/Exclusion criteria may apply.
medicalinfo@vrtx.com617-341-6777
Thousand Oaks, California 91320, United States
Washington D.C., District of Columbia 20016, United States
Boston, Massachusetts 02115, United States
New York, New York 10032, United States
Winston-Salem, North Carolina 27103, United States
Charleston, South Carolina 29406, United States